Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

calcium and cholecalciferol

Tablet to suck: calcium 500 mg bid, cholecalciferol 200 IU bid

DRUG

calcium and cholecalciferol

"Tablet: calcium 500 mg bid + 2 ml drinkable solution cholecalciferol 100 000 IU whose schedule of administration depends on vitamin deficiency level:~* 100 000 IU of vitamin D3 at D1, D15, D28 and D43 if 25-OHD level \< 10 ng/mL~* 100 000 IU of vitamin D3 at D1, D15, D28 if 10 ng/mL ≤ 25-OHD level \< 20 ng/mL~* 100 000 IU of vitamin D3 at D1 if 20 ng/mL ≤ 25-OHD level \< 30 ng/mL"

Trial Locations (1)

34298

CRLC Val d'Aurelle-Paul Lamarque, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT01480869 - Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients | Biotech Hunter | Biotech Hunter